Accendra Health director granted 31,191 phantom units

Bingham Gwendolyn M reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Bingham Gwendolyn M reported acquisition or exercise transactions in this Form 4 filing.

Accendra Health director Gwendolyn M. Bingham received a grant of 31,191 phantom stock units on May 14, 2026 at no cost. This award increases her phantom stock holdings to 80,603 units. Each phantom unit is convertible on a 1-for-1 basis into common stock and becomes payable, in cash or common stock at her election, upon events such as death, disability, termination of service as director, or a preselected future delivery date.

Insider Trade Summary

Grant/Award: 31,191 shares

Grant/Award 1 txn

Insider Bingham Gwendolyn M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock	31,191	$0.00	$0.00

Holdings After Transaction: Phantom Stock — 80,603 contracts (Direct)

Footnotes (1)

1. F1. The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Key Figures

Phantom stock grant: 31,191 units Total phantom stock holdings: 80,603 units Grant price: $0.0000 per unit +1 more

4 metrics

Phantom stock grant 31,191 units Grant on May 14, 2026 to director Gwendolyn M. Bingham

Total phantom stock holdings 80,603 units Phantom stock units held following the reported transaction

Grant price $0.0000 per unit Phantom stock award provided at no cash cost to the director

Conversion ratio 1-for-1 Each phantom stock unit convertible into one share of common stock

Key Terms

Phantom Stock, 1-for-1 basis, termination of service as director, specified future delivery date

4 terms

Phantom Stock financial

"The shares of phantom stock are convertible on a 1-for-1 basis"

A phantom stock is a form of compensation that gives employees or executives the benefits of stock ownership, such as the increase in stock value, without actually giving them real shares. It acts like a promise to pay the employee the equivalent value of company stock later, often as a bonus or incentive. This allows companies to motivate and reward staff without diluting ownership or transferring actual shares.

1-for-1 basis financial

"The shares of phantom stock are convertible on a 1-for-1 basis"

termination of service as director financial

"termination of service as director, (d) specified future delivery date"

specified future delivery date financial

"termination of service as director, (d) specified future delivery date, or (e)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Accendra Health (ACH) report for Gwendolyn M. Bingham?

Accendra Health reported that director Gwendolyn M. Bingham received a grant of 31,191 phantom stock units. These units were awarded at no cost and increase her total phantom stock holdings to 80,603 units, providing deferred, equity-linked compensation tied to the company’s common stock.

How many phantom stock units does Gwendolyn M. Bingham hold after this Form 4?

After the reported grant, Gwendolyn M. Bingham holds 80,603 phantom stock units. This total includes the new 31,191-unit award, reflecting her accumulated deferred compensation that is linked in value to Accendra Health’s common stock on a one-for-one basis.

What are the key terms of the phantom stock granted by Accendra Health (ACH)?

Each phantom stock unit is convertible on a 1-for-1 basis into common stock and becomes payable in cash or common stock. Payment occurs upon a triggering event such as death, disability, termination of service as director, a specified future delivery date, or the earliest of these elected events.

Is the phantom stock grant to Gwendolyn M. Bingham an open-market purchase or sale?

The phantom stock grant is not an open-market purchase or sale; it is a compensation-related award. The Form 4 uses transaction code “A,” indicating a grant, award, or other acquisition of derivative securities provided by the company rather than a market transaction.

When can Gwendolyn M. Bingham receive value from her Accendra Health phantom stock units?

Value from the phantom stock units becomes payable upon specific events elected in advance, including death, disability, termination of service as director, or a specified future delivery date. At that time, the award is settled in cash or common stock at the reporting person’s election.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 09:11 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bingham Gwendolyn M

(Last) (First) (Middle)

ACCENDRA HEALTH, INC.

4435 WATERFRONT DRIVE

(Street)

GLEN ALLEN VIRGINIA 23060

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACCENDRA HEALTH INC/VA/ [ ACH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock	(1)	05/14/2026		A		31,191		(1)	(1)	Common Stock	31,191	$0	80,603	D

Explanation of Responses:

1. The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

	Gwendolyn M. Bingham, by Rosemarie France POA	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)